IMMX Immix Biopharma, Inc.
$12.14▼ -4.41%
Healthcare
Other
After hours
$12.21▲ +0.58%
Sep 11, 7:30 PM ET
Volume 1.19M
Avg Volume (10D) 1.32M
Key Metrics & Fundamentals
Market Cap
$868.49M
P/E Ratio
–
Div Yield
–%
52W Range
1.94 - 15.10
% vs 50 MA
8.21%
% vs 200 MA
39.89%
RSI-14
46.7
MACD Histogram
-0.3100
Beta (1Y vs SPY)
1.61
Free Cash Flow
-$11.76M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$12.33M
COGS
–
Operating Exp
$12.46M
Operating Income
-$12.46M
EBIT
-$12.46M
Pretax Income
-$11.54M
Net Income
-$11.56M
EPS (Diluted)
-0.18
Price & Volume History
Loading chart…
Recent News
Morgan Stanley Adjusts PT on Immix Biopharma to $19 From $20, Maintains Overweight Rating
MT Newswires · Aug 11, 2026 9:31 AM
Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Aug 4, 2026 1:15 PM
Needham Initiates Immix Biopharma at Buy With $21 Price Target
MT Newswires · Jul 22, 2026 11:19 AM
Straight Out Of A Soap Opera: Biotech Exec Arrested After 21 Years On The Run
Investor's Business Daily · Jul 21, 2026 9:17 PM
Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet
Zacks · Jun 18, 2026 1:55 PM
BofA Initiates Immix Biopharma at Buy With $27 Price Target
MT Newswires · Jun 18, 2026 11:55 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See IMMX's money flow as a full page
Social Sentiment
No Reddit posts found for IMMX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.